NIP
JAZZ icon

Nicholas Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nicholas Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,552
Closed -$4.77M – 189
2022
Q2 		$4.77M Buy
+30,552
New +$4.7M 0.45% 84
2018
Q4 		– Sell
-19,450
Closed -$3.27M – 230
2018
Q3 		$3.27M Sell
19,450
-1,179
-6% -$203K 0.26% 150
2018
Q2 		$3.55M Buy
20,629
+1,734
+9% +$283K 0.25% 132
2018
Q1 		$2.85M Buy
18,895
+1,541
+9% +$226K 0.2% 160
2017
Q4 		$2.34M Sell
17,354
-4,621
-21% -$641K 0.15% 193
2017
Q3 		$3.21M Sell
21,975
-275
-1% -$41.6K 0.22% 158
2017
Q2 		$3.46M Buy
22,250
+174
+0.8% +$26.6K 0.24% 146
2017
Q1 		$3.2M Buy
+22,076
New +$2.88M 0.23% 164
2016
Q4 		– Sell
-29,954
Closed -$3.64M – 312
2016
Q3 		$3.64M Sell
29,954
-750
-2% -$101K 0.24% 165
2016
Q2 		$4.34M Buy
30,704
+20,309
+195% +$2.99M 0.3% 123
2016
Q1 		$1.36M Sell
10,395
-3,173
-23% -$395K 0.1% 264
2015
Q4 		$1.91M Sell
13,568
-900
-6% -$125K 0.13% 259
2015
Q3 		$1.92M Sell
14,468
-124
-0.8% -$21.4K 0.14% 249
2015
Q2 		$2.57M Sell
14,592
-15,700
-52% -$2.82M 0.16% 234
2015
Q1 		$5.23M Sell
30,292
-84
-0.3% -$14.4K 0.33% 101
2014
Q4 		$4.97M Buy
30,376
+29
+0.1% +$4.81K 0.31% 123
2014
Q3 		$4.87M Buy
+30,347
New +$4.67M 0.3% 99
2014
Q1 		– Sell
-21,736
Closed -$2.75M – 309
2013
Q4 		$2.75M Sell
21,736
-11,995
-36% -$1.24M 0.21% 130
2013
Q3 		$3.1M Buy
33,731
+7,764
+30% +$626K 0.26% 101
2013
Q2 		$1.78M Buy
+25,967
New +$1.59M 0.17% 207

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nicholas Investment Partners's JAZZ Position: Q3 2022 in Review

Nicholas Investment Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2022, closing a stake of 30,552 shares — an estimated $4.77M sold.

Nicholas Investment Partners first reported a position in JAZZ in Q2 2013 and held it in 20 quarters. The position peaked at $5.23M in Q1 2015. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

  • Nicholas Investment Partners reported no remaining Jazz Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 30,552 Jazz Pharmaceuticals shares in Q3 2022, an estimated $4.77M.
  • Nicholas Investment Partners first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Nicholas Investment Partners's Jazz Pharmaceuticals position peaked at $5.23M in Q1 2015.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.